Cattle Health Market - Growth, Trends, and Forecasts (2020 - 2025)

The Cattle Health Market is segmented by Product Type (Therapeutics and Diagnostics), and Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The market for cattle health is being driven by factors such as increasing R&D expenditure in the cattle health sector, rising initiatives by government, and animal welfare associations and advanced technology leading to innovations in the cattle health sector.

European countries along with the countries in the Asia Pacific are focusing more on the cattle health and implementing several initiatives for the same. For instance, in the United Kingdom, the Cattle Health and Welfare Group (CHAWG) has a crucial role in addressing relevant cattle health and welfare issues. CHAWG is responsible for planning and coordinating a program of economically-focused improvements for cattle health and welfare. CHAWG acts as the first point of call for all cattle health and welfare research, and new disease challenges. Also, countries such as the Netherlands and Germany are having private and public-private partnership insurance schemes are available for cattle, which compensate for consequential losses. In Italy, private insurance schemes are exclusively for dairy production and sheep, but participation is very limited.

Considering the Asia Pacific region, in Australia, the Animal Welfare Task Group developed animal welfare standards and guidelines for cattle and sheep. In addition, an electronic identification system has been developed for the livestock, named national livestock identification system (NLIS), in which, an animal is tagged with a radiofrequency identification device.

Owing to the rising focus on cattle health and involvement of the government, it is expected that the market for cattle health will grow in the coming future.

Scope of the Report

Cattle healthcare includes the treatment and diagnosis of cattle. Cattle healthcare is being fueled by the increasing beef consumption and rising demand for animal protein in the market. 

By Product Type
By Therapeutics
Vaccine
Parasiticide
Anti-infective
Medical Feed Additive
Other Therapeutics
By Diagnostics
Immunodiagnostic Test
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines are Expected Dominate the Therapeutics Segment Over the Forecast Period.

Vaccination of the beef cattle herds is designed to protect the cattle from different kinds of microorganisms, such as viruses, bacteria, and protozoans. Most of the vaccines used for cattle are injectables. However, some of the vaccines are given by intranasal or oral route.

The vaccines used for cattle health include modified live organisms, killed or chemically altered organisms. With the right use of the vaccine, cattle’s resistance toward the disease may be increased, irrespective of the type of vaccine used. The modified live vaccines contain little amount of viruses or bacteria, which are used for the single-dose purpose and may not develop allergic reactions in the cattle.

The killed vaccines or toxoids are available for various types of disease and are likely to cause allergic reactions. The chemically altered vaccines show similar results like the modified live vaccines. The rising cattle population, increasing R&D expenditure and latest technologies are helping the vaccine segment to expand its reach. The market is inclusive of different kind of vaccines, such as vaccination for respiratory diseases, clostridial vaccines, botulism vaccine, and vaccination for diseases that cause infertility or abortion in the cattle. In addition to the above-mentioned list, vaccines are also available for some of the specific diseases, such as bovine ephemeral fever, anthrax, tick fever, etc.

The availability of such vaccines is the result of R&D efforts taken by the companies and the increasing awareness among people about cattle health.

To understand key trends, Download Sample Report

North America Dominates the Market

North America is believed to dominate the market due to increasing R&D expenditure in cattle health and advanced technology leading to innovations in the cattle health sector in this country, which, in turn, helps in the growth of this market.

Due to the huge demand for dairy products in the United States, there is a huge requirement of cattle population. Cattle health products are very important for maintaining cattle health and to increase the cattle population. However, the registration of new cattle health products or import of the same requires to go through various tests and certifications, before being allowed to enter the market.

To understand geography trends, Download Sample Report.

Competitive Landscape

The cattle health market includes the major players such as Bayer AG, Boehringer Ingelheim, Ceva Sante Animale, Elanco Animal Health, IDVet, Merck & Co, Inc., Virbac, and Zoetis Inc., amongst others. Few of the companies such as Elanco, Ceva, Zoetis Inc., etc. are dominating the market and there are some local players which are holding a substantial share.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Expenditure in the Cattle Health Sector

      2. 4.2.2 Increasing Initiatives by Government and Animal Welfare Associations

      3. 4.2.3 Advanced Technology Leading to Innovations in the Cattle Health Sector

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Infrastructure and Funding

      2. 4.3.2 Increasing Costs of Animal Testing and Veterinary Services

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Vaccine

        2. 5.1.1.2 Parasiticide

        3. 5.1.1.3 Anti-infective

        4. 5.1.1.4 Medical Feed Additive

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Immunodiagnostic Test

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Clinical Chemistry

        5. 5.1.2.5 Other Diagnostics

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Inc.

      2. 6.1.2 Merck & Co, Inc.

      3. 6.1.3 IDVet

      4. 6.1.4 Elanco Animal Health

      5. 6.1.5 Bayer AG

      6. 6.1.6 Ceva Sante Animale

      7. 6.1.7 Virbac

      8. 6.1.8 Boehringer Ingelheim

      9. 6.1.9 Idexx Laboratories

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports